June 5, 2020
Polyneuron’s PN-1007 Receives U.S. FDA Orphan Drug Designation in Anti-MAG Neuropathy
Myelin Binding Data also Published in Journal of Neurochemistry BASEL, Switzerland–(BUSINESS WIRE)–Polyneuron Pharmaceuticals AG, a clinical stage developer of a…